| Year |
Citation |
Score |
| 2024 |
George MF, Paff S, Rojo J, Powell M, Benz C, Pope K, Kerlikowske K, Shepard J, Willis M, Ereman R, Prebil L. Assessment of salivary cadmium levels and breast density in the Marin Women's Study. Cancer Medicine. 13: e6973. PMID 38379324 DOI: 10.1002/cam4.6973 |
0.302 |
|
| 2023 |
Clelland EN, Rothschild HT, Patterson A, Molina-Vega J, Kaur M, Symmans WF, Schwartz CJ, Chien AJ, Benz CC, Mukhtar RA. Quantifying hormone receptor status in lobular breast cancer in an institutional series: the relationship between estrogen and progesterone receptor status and outcomes. Breast Cancer Research and Treatment. PMID 37500962 DOI: 10.1007/s10549-023-07059-y |
0.347 |
|
| 2023 |
Heckenbach I, Powell M, Fuller S, Henry J, Rysdyk S, Cui J, Teklu AA, Verdin E, Benz C, Scheibye-Knudsen M. Breast cancer risk based on a deep learning predictor of senescent cells in normal tissue. Medrxiv : the Preprint Server For Health Sciences. PMID 37292628 DOI: 10.1101/2023.05.22.23290327 |
0.363 |
|
| 2022 |
Powell M, Fuller S, Gunderson E, Benz C. A common IGF1R gene variant predicts later life breast cancer risk in women with preeclampsia. Breast Cancer Research and Treatment. PMID 36331687 DOI: 10.1007/s10549-022-06789-9 |
0.332 |
|
| 2022 |
Johansson A, Dar H, van 't Veer LJ, Tobin NP, Perez-Tenorio G, Nordenskjöld A, Johansson U, Hartman J, Skoog L, Yau C, Benz CC, Esserman LJ, Stål O, Nordenskjöld B, Fornander T, et al. Twenty-Year Benefit From Adjuvant Goserelin and Tamoxifen in Premenopausal Patients With Breast Cancer in a Controlled Randomized Clinical Trial. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO2102844. PMID 35862873 DOI: 10.1200/JCO.21.02844 |
0.338 |
|
| 2022 |
Johansson A, Yu NY, Iftimi A, Tobin NP, van 't Veer L, Nordenskjöld B, Benz CC, Fornander T, Perez-Tenorio G, Stål O, Esserman LJ, Yau C, Lindström LS. Clinical and molecular characteristics of estrogen receptor-positive ultralow risk breast cancer tumors identified by the 70-gene signature. International Journal of Cancer. PMID 35179782 DOI: 10.1002/ijc.33969 |
0.352 |
|
| 2021 |
Rothschild HT, Abel MK, Patterson A, Goodman K, Shui A, van Baelen K, Desmedt C, Benz C, Mukhtar RA. Obesity and menopausal status impact the features and molecular phenotype of invasive lobular breast cancer. Breast Cancer Research and Treatment. 191: 451-458. PMID 34817747 DOI: 10.1007/s10549-021-06453-8 |
0.307 |
|
| 2021 |
Dar H, Johansson A, Nordenskjöld A, Iftimi A, Yau C, Perez-Tenorio G, Benz C, Nordenskjöld B, Stål O, Esserman LJ, Fornander T, Lindström LS. Assessment of 25-Year Survival of Women With Estrogen Receptor-Positive/ERBB2-Negative Breast Cancer Treated With and Without Tamoxifen Therapy: A Secondary Analysis of Data From the Stockholm Tamoxifen Randomized Clinical Trial. Jama Network Open. 4: e2114904. PMID 34190995 DOI: 10.1001/jamanetworkopen.2021.14904 |
0.356 |
|
| 2021 |
Johansson A, Christakou AE, Iftimi A, Eriksson M, Tapia J, Skoog L, Benz CC, Rodriguez-Wallberg KA, Hall P, Czene K, Lindström LS. Characterization of Benign Breast Diseases and Association With Age, Hormonal Factors, and Family History of Breast Cancer Among Women in Sweden. Jama Network Open. 4: e2114716. PMID 34170304 DOI: 10.1001/jamanetworkopen.2021.14716 |
0.372 |
|
| 2020 |
Kang T, Yau C, Wong CK, Sanborn JZ, Newton Y, Vaske C, Benz SC, Krings G, Camarda R, Henry JE, Stuart J, Powell M, Benz CC. A risk-associated Active transcriptome phenotype expressed by histologically normal human breast tissue and linked to a pro-tumorigenic adipocyte population. Breast Cancer Research : Bcr. 22: 81. PMID 32736587 DOI: 10.1186/S13058-020-01322-6 |
0.391 |
|
| 2019 |
Powell MJ, Dufault SM, Henry JE, Allison AC, Cora R, Benz CC. Pregnancy Hypertension and a Commonly Inherited IGF1R Variant (rs2016347) Reduce Breast Cancer Risk by Enhancing Mammary Gland Involution. Journal of Oncology. 2019: 6018432. PMID 31687025 DOI: 10.1155/2019/6018432 |
0.389 |
|
| 2019 |
Yu NY, Iftimi A, Yau C, Tobin NP, van 't Veer L, Hoadley KA, Benz CC, Nordenskjöld B, Fornander T, Stål O, Czene K, Esserman LJ, Lindström LS. Assessment of Long-term Distant Recurrence-Free Survival Associated With Tamoxifen Therapy in Postmenopausal Patients With Luminal A or Luminal B Breast Cancer. Jama Oncology. PMID 31393518 DOI: 10.1001/Jamaoncol.2019.1856 |
0.333 |
|
| 2018 |
Lindström LS, Yau C, Czene K, Thompson CK, Hoadley KA, Van't Veer LJ, Balassanian R, Bishop JW, Carpenter PM, Chen YY, Datnow B, Hasteh F, Krings G, Lin F, Zhang Y, ... ... Benz CC, et al. Intratumor Heterogeneity of the Estrogen Receptor and the Long-term Risk of Fatal Breast Cancer. Journal of the National Cancer Institute. PMID 29361175 DOI: 10.1093/Jnci/Djx270 |
0.382 |
|
| 2017 |
Zhou Y, Zou H, Yau C, Zhao L, Hall SC, Drummond DC, Farr-Jones S, Park JW, Benz CC, Marks JD. Discovery of internalizing antibodies to basal breast cancer cells. Protein Engineering, Design & Selection : Peds. PMID 29301020 DOI: 10.1093/Protein/Gzx063 |
0.369 |
|
| 2017 |
Scott GK, Chu D, Kaur R, Malato J, Rothschild DE, Frazier K, Eppenberger-Castori S, Hann B, Park BH, Benz CC. ERpS294 is a biomarker of ligand or mutational ERα activation and a breast cancer target for CDK2 inhibition. Oncotarget. 8: 83432-83445. PMID 29137354 DOI: 10.18632/Oncotarget.12735 |
0.334 |
|
| 2017 |
Powell MJ, Von Behren J, Neuhausen S, Reynolds P, Benz CC. Functional IGF1R variant predicts breast cancer risk in women with preeclampsia in California Teachers Study. Cancer Causes & Control : Ccc. PMID 28822014 DOI: 10.1007/s10552-017-0942-7 |
0.319 |
|
| 2017 |
Esserman LJ, Yau C, Thompson CK, van 't Veer LJ, Borowsky AD, Hoadley KA, Tobin NP, Nordenskjöld B, Fornander T, Stål O, Benz CC, Lindström LS. Use of Molecular Tools to Identify Patients With Indolent Breast Cancers With Ultralow Risk Over 2 Decades. Jama Oncology. PMID 28662222 DOI: 10.1001/Jamaoncol.2017.1261 |
0.327 |
|
| 2017 |
Huo D, Hu H, Rhie SK, Gamazon ER, Cherniack AD, Liu J, Yoshimatsu TF, Pitt JJ, Hoadley KA, Troester M, Ru Y, Lichtenberg T, Sturtz LA, Shelley CS, Benz CC, et al. Comparison of Breast Cancer Molecular Features and Survival by African and European Ancestry in The Cancer Genome Atlas. Jama Oncology. PMID 28472234 DOI: 10.1001/Jamaoncol.2017.0595 |
0.364 |
|
| 2016 |
Troester MA, Hoadley KA, D'Arcy M, Cherniack AD, Stewart C, Koboldt DC, Robertson AG, Mahurkar S, Shen H, Wilkerson MD, Sandhu R, Johnson NB, Allison KH, Beck AH, Yau C, ... ... Benz CC, et al. DNA defects, epigenetics, and gene expression in cancer-adjacent breast: a study from The Cancer Genome Atlas. Npj Breast Cancer. 2: 16007. PMID 28721375 DOI: 10.1038/npjbcancer.2016.7 |
0.384 |
|
| 2016 |
Esserman L, Benz C, Demichele A. Targeting Molecular Aberrations in Breast Cancer: Is It about Time? American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting. 186-91. PMID 24451732 DOI: 10.14694/EdBook_AM.2012.32.186 |
0.366 |
|
| 2015 |
Yau C, Meyer L, Benz S, Vaske C, Scott G, Egan B, Labhart P, Pourmand N, Benz CC. FOXM1 cistrome predicts breast cancer metastatic outcome better than FOXM1 expression levels or tumor proliferation index. Breast Cancer Research and Treatment. 154: 23-32. PMID 26456572 DOI: 10.1007/S10549-015-3589-7 |
0.414 |
|
| 2015 |
Ciriello G, Gatza ML, Beck AH, Wilkerson MD, Rhie SK, Pastore A, Zhang H, McLellan M, Yau C, Kandoth C, Bowlby R, Shen H, Hayat S, Fieldhouse R, Lester SC, ... ... Benz C, et al. Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer. Cell. 163: 506-19. PMID 26451490 DOI: 10.1016/J.Cell.2015.09.033 |
0.389 |
|
| 2015 |
Mockus M, Prebil L, Ereman R, Dollbaum C, Powell M, Yau C, Benz CC. First Pregnancy Characteristics, Postmenopausal Breast Density, and Salivary Sex Hormone Levels in a Population at High Risk for Breast Cancer. Bba Clinical. 3: 189-195. PMID 26317068 DOI: 10.1016/j.bbacli.2015.02.003 |
0.34 |
|
| 2015 |
DeMichele A, Yee D, Berry DA, Albain KS, Benz CC, Boughey J, Buxton M, Chia SK, Chien AJ, Chui SY, Clark A, Edmiston K, Elias AD, Forero-Torres A, Haddad TC, et al. The Neoadjuvant Model Is Still the Future for Drug Development in Breast Cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 21: 2911-5. PMID 25712686 DOI: 10.1158/1078-0432.Ccr-14-1760 |
0.323 |
|
| 2014 |
Wilson-Edell KA, Kehasse A, Scott GK, Yau C, Rothschild DE, Schilling B, Gabriel BS, Yevtushenko MA, Hanson IM, Held JM, Gibson BW, Benz CC. RPL24: a potential therapeutic target whose depletion or acetylation inhibits polysome assembly and cancer cell growth. Oncotarget. 5: 5165-76. PMID 24970821 DOI: 10.18632/Oncotarget.2099 |
0.352 |
|
| 2014 |
Wilson-Edell KA, Yevtushenko MA, Rothschild DE, Rogers AN, Benz CC. mTORC1/C2 and pan-HDAC inhibitors synergistically impair breast cancer growth by convergent AKT and polysome inhibiting mechanisms. Breast Cancer Research and Treatment. 144: 287-98. PMID 24562770 DOI: 10.1007/s10549-014-2877-y |
0.386 |
|
| 2014 |
Zawadzka AM, Schilling B, Cusack MP, Sahu AK, Drake P, Fisher SJ, Benz CC, Gibson BW. Phosphoprotein secretome of tumor cells as a source of candidates for breast cancer biomarkers in plasma. Molecular & Cellular Proteomics : McP. 13: 1034-49. PMID 24505115 DOI: 10.1074/Mcp.M113.035485 |
0.366 |
|
| 2013 |
Yau C, Sninsky J, Kwok S, Wang A, Degnim A, Ingle JN, Gillett C, Tutt A, Waldman F, Moore D, Esserman L, Benz CC. An optimized five-gene multi-platform predictor of hormone receptor negative and triple negative breast cancer metastatic risk. Breast Cancer Research : Bcr. 15: R103. PMID 24172169 DOI: 10.1186/bcr3567 |
0.386 |
|
| 2012 |
Sadanandam A, Lal A, Benz SC, Eppenberger-Castori S, Scott G, Gray JW, Spellman P, Waldman F, Benz CC. Genomic aberrations in normal tissue adjacent to HER2-amplified breast cancers: field cancerization or contaminating tumor cells? Breast Cancer Research and Treatment. 136: 693-703. PMID 23104223 DOI: 10.1007/S10549-012-2290-3 |
0.352 |
|
| 2011 |
Esserman LJ, Moore DH, Tsing PJ, Chu PW, Yau C, Ozanne E, Chung RE, Tandon VJ, Park JW, Baehner FL, Kreps S, Tutt AN, Gillett CE, Benz CC. Biologic markers determine both the risk and the timing of recurrence in breast cancer. Breast Cancer Research and Treatment. 129: 607-16. PMID 21597921 DOI: 10.1007/s10549-011-1564-5 |
0.307 |
|
| 2011 |
Pettersson F, Yau C, Dobocan MC, Culjkovic-Kraljacic B, Retrouvey H, Retrouvay H, Puckett R, Flores LM, Krop IE, Rousseau C, Cocolakis E, Borden KL, Benz CC, Miller WH. Ribavirin treatment effects on breast cancers overexpressing eIF4E, a biomarker with prognostic specificity for luminal B-type breast cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 17: 2874-84. PMID 21415224 DOI: 10.1158/1078-0432.Ccr-10-2334 |
0.424 |
|
| 2011 |
Yau C, Wang Y, Zhang Y, Foekens JA, Benz CC. Young age, increased tumor proliferation and FOXM1 expression predict early metastatic relapse only for endocrine-dependent breast cancers. Breast Cancer Research and Treatment. 126: 803-10. PMID 21225456 DOI: 10.1007/s10549-011-1345-1 |
0.4 |
|
| 2010 |
Yau C, Esserman L, Moore DH, Waldman F, Sninsky J, Benz CC. A multigene predictor of metastatic outcome in early stage hormone receptor-negative and triple-negative breast cancer. Breast Cancer Research : Bcr. 12: R85. PMID 20946665 DOI: 10.1186/bcr2753 |
0.399 |
|
| 2010 |
Ereman RR, Prebil LA, Mockus M, Koblick K, Orenstein F, Benz C, Clarke CA. Recent trends in hormone therapy utilization and breast cancer incidence rates in the high incidence population of Marin County, California. Bmc Public Health. 10: 228. PMID 20433756 DOI: 10.1186/1471-2458-10-228 |
0.354 |
|
| 2009 |
Atsriku C, Britton DJ, Held JM, Schilling B, Scott GK, Gibson BW, Benz CC, Baldwin MA. Systematic mapping of posttranslational modifications in human estrogen receptor-alpha with emphasis on novel phosphorylation sites. Molecular & Cellular Proteomics : McP. 8: 467-80. PMID 18984578 DOI: 10.1074/Mcp.M800282-Mcp200 |
0.34 |
|
| 2008 |
Park JW, Neve RM, Szollosi J, Benz CC. Unraveling the biologic and clinical complexities of HER2. Clinical Breast Cancer. 8: 392-401. PMID 18952552 DOI: 10.3816/CBC.2008.n.047 |
0.383 |
|
| 2008 |
Yau C, Benz CC. Genes responsive to both oxidant stress and loss of estrogen receptor function identify a poor prognosis group of estrogen receptor positive primary breast cancers. Breast Cancer Research : Bcr. 10: R61. PMID 18631401 DOI: 10.1186/bcr2120 |
0.339 |
|
| 2008 |
Kumar AS, Benz CC, Shim V, Minami CA, Moore DH, Esserman LJ. Estrogen receptor-negative breast cancer is less likely to arise among lipophilic statin users. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 17: 1028-33. PMID 18463402 DOI: 10.1158/1055-9965.EPI-07-0726 |
0.363 |
|
| 2008 |
Benz CC. Impact of aging on the biology of breast cancer. Critical Reviews in Oncology/Hematology. 66: 65-74. PMID 17949989 DOI: 10.1016/j.critrevonc.2007.09.001 |
0.407 |
|
| 2007 |
Yau C, Fedele V, Roydasgupta R, Fridlyand J, Hubbard A, Gray JW, Chew K, Dairkee SH, Moore DH, Schittulli F, Tommasi S, Paradiso A, Albertson DG, Benz CC. Aging impacts transcriptomes but not genomes of hormone-dependent breast cancers. Breast Cancer Research : Bcr. 9: R59. PMID 17850661 DOI: 10.1186/Bcr1765 |
0.395 |
|
| 2007 |
Vuaroqueaux V, Urban P, Labuhn M, Delorenzi M, Wirapati P, Benz CC, Flury R, Dieterich H, Spyratos F, Eppenberger U, Eppenberger-Castori S. Low E2F1 transcript levels are a strong determinant of favorable breast cancer outcome. Breast Cancer Research : Bcr. 9: R33. PMID 17535433 DOI: 10.1186/bcr1681 |
0.34 |
|
| 2007 |
Tommasi S, Fedele V, Lacalamita R, Bruno M, Schittulli F, Ginzinger D, Scott G, Eppenberger-Castori S, Calistri D, Casadei S, Seymour I, Longo S, Giannelli G, Pilato B, Simone G, ... Benz CC, et al. 655Val and 1170Pro ERBB2 SNPs in familial breast cancer risk and BRCA1 alterations. Cellular Oncology : the Official Journal of the International Society For Cellular Oncology. 29: 241-8. PMID 17452776 |
0.377 |
|
| 2007 |
Zhou Y, Yau C, Gray JW, Chew K, Dairkee SH, Moore DH, Eppenberger U, Eppenberger-Castori S, Benz CC. Enhanced NF kappa B and AP-1 transcriptional activity associated with antiestrogen resistant breast cancer. Bmc Cancer. 7: 59. PMID 17407600 DOI: 10.1186/1471-2407-7-59 |
0.353 |
|
| 2007 |
Marx C, Yau C, Banwait S, Zhou Y, Scott GK, Hann B, Park JW, Benz CC. Proteasome-regulated ERBB2 and estrogen receptor pathways in breast cancer. Molecular Pharmacology. 71: 1525-34. PMID 17392524 DOI: 10.1124/mol.107.034090 |
0.381 |
|
| 2007 |
Kumar AS, Cureton E, Shim V, Sakata T, Moore DH, Benz CC, Esserman LJ, Hwang ES. Type and duration of exogenous hormone use affects breast cancer histology. Annals of Surgical Oncology. 14: 695-703. PMID 17103262 DOI: 10.1245/s10434-006-9129-2 |
0.393 |
|
| 2006 |
Benz CC, Atsriku C, Yau C, Britton D, Schilling B, Gibson BW, Baldwin MA, Scott GK. Novel pathways associated with quinone-induced stress in breast cancer cells. Drug Metabolism Reviews. 38: 601-13. PMID 17145690 DOI: 10.1080/03602530600959391 |
0.408 |
|
| 2006 |
Urban P, Vuaroqueaux V, Labuhn M, Delorenzi M, Wirapati P, Wight E, Senn HJ, Benz C, Eppenberger U, Eppenberger-Castori S. Increased expression of urokinase-type plasminogen activator mRNA determines adverse prognosis in ErbB2-positive primary breast cancer Journal of Clinical Oncology. 24: 4245-4253. PMID 16963728 DOI: 10.1200/JCO.2005.05.1912 |
0.357 |
|
| 2006 |
Campbell MJ, Esserman LJ, Zhou Y, Shoemaker M, Lobo M, Borman E, Baehner F, Kumar AS, Adduci K, Marx C, Petricoin EF, Liotta LA, Winters M, Benz S, Benz CC. Breast cancer growth prevention by statins. Cancer Research. 66: 8707-14. PMID 16951186 DOI: 10.1158/0008-5472.Can-05-4061 |
0.388 |
|
| 2006 |
Benz CC, Fedele V, Xu F, Ylstra B, Ginzinger D, Yu M, Moore D, Hall RK, Wolff DJ, Disis ML, Eppenberger-Castori S, Eppenberger U, Schittulli F, Tommasi S, Paradiso A, et al. Altered promoter usage characterizes monoallelic transcription arising with ERBB2 amplification in human breast cancers. Genes, Chromosomes & Cancer. 45: 983-94. PMID 16883574 DOI: 10.1002/Gcc.20364 |
0.391 |
|
| 2006 |
Marx C, Berger C, Xu F, Amend C, Scott GK, Hann B, Park JW, Benz CC. Validated high-throughput screening of drug-like small molecules for inhibitors of ErbB2 transcription. Assay and Drug Development Technologies. 4: 273-84. PMID 16834533 DOI: 10.1089/adt.2006.4.273 |
0.311 |
|
| 2006 |
Kirpotin DB, Drummond DC, Shao Y, Shalaby MR, Hong K, Nielsen UB, Marks JD, Benz CC, Park JW. Antibody targeting of long-circulating lipidic nanoparticles does not increase tumor localization but does increase internalization in animal models. Cancer Research. 66: 6732-40. PMID 16818648 DOI: 10.1158/0008-5472.Can-05-4199 |
0.311 |
|
| 2006 |
Kumar AS, Campbell M, Benz CC, Esserman LJ. A call for clinical trials: lipophilic statins may prove effective in treatment and prevention of particular breast cancer subtypes. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 24: 2127; author reply 2. PMID 16648516 DOI: 10.1200/JCO.2005.04.9882 |
0.329 |
|
| 2005 |
Zhou Y, Eppenberger-Castori S, Marx C, Yau C, Scott GK, Eppenberger U, Benz CC. Activation of nuclear factor-kappaB (NFkappaB) identifies a high-risk subset of hormone-dependent breast cancers. The International Journal of Biochemistry & Cell Biology. 37: 1130-44. PMID 15743683 DOI: 10.1016/j.biocel.2004.09.006 |
0.41 |
|
| 2005 |
Hwang ES, Chew T, Shiboski S, Farren G, Benz CC, Wrensch M. Risk factors for estrogen receptor-positive breast cancer. Archives of Surgery (Chicago, Ill. : 1960). 140: 58-62. PMID 15655207 DOI: 10.1001/archsurg.140.1.58 |
0.4 |
|
| 2003 |
Benz CC, Clarke CA, Moore DH. Geographic excess of estrogen receptor-positive breast cancer. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 12: 1523-7. PMID 14693747 |
0.405 |
|
| 2003 |
Meza JE, Scott GK, Benz CC, Baldwin MA. Essential cysteine-alkylation strategies to monitor structurally altered estrogen receptor as found in oxidant-stressed breast cancers. Analytical Biochemistry. 320: 21-31. PMID 12895466 |
0.362 |
|
| 2002 |
Scott GK, Marden C, Xu F, Kirk L, Benz CC. Transcriptional repression of ErbB2 by histone deacetylase inhibitors detected by a genomically integrated ErbB2 promoter-reporting cell screen. Molecular Cancer Therapeutics. 1: 385-92. PMID 12477051 |
0.323 |
|
| 2002 |
Quong J, Eppenberger-Castori S, Moore D, Scott GK, Birrer MJ, Kueng W, Eppenberger U, Benz CC. Age-dependent changes in breast cancer hormone receptors and oxidant stress markers. Breast Cancer Research and Treatment. 76: 221-36. PMID 12462383 |
0.418 |
|
| 2002 |
Eppenberger-Castori S, Moore DH, Thor AD, Edgerton SM, Kueng W, Eppenberger U, Benz CC. Age-associated biomarker profiles of human breast cancer. The International Journal of Biochemistry & Cell Biology. 34: 1318-30. PMID 12200028 |
0.399 |
|
| 2002 |
Neve RM, Ylstra B, Chang CH, Albertson DG, Benz CC. ErbB2 activation of ESX gene expression. Oncogene. 21: 3934-8. PMID 12032832 DOI: 10.1038/sj.onc.1205503 |
0.307 |
|
| Show low-probability matches. |